PTX3-targeted prophylaxis
PTX3 genetically stratified randomized double-blinded allocation event-driven clinical trial for antifungal prophylaxis in patients with acute myeloid leukemia
- Principal investigator: Prof. Dr. Johan Maertens
- More information: NCT03828773
- Internal reference number: S62099
PC_ASP_006
A double-blind, randomized, placebo-controlled study to assess the safety and efficacy of nebulized PC945 when added to systemic antifungal therapy for the treatment of refractory invasive pulmonary Aspergillosis
- Principal investigator: Prof. Dr. Johan Maertens
- More information: NCT05238116
- Internal reference number: S66632
FMGX-CS-302
An interventional Phase 3, open-label, two-cohort study to investigate the efficacy and safety of fosmanogepix in adult patients with invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds
- Principal investigator: Prof. Dr. Johan Maertens
- More information: NCT06925321
- Internal reference number: S70029
Vragen en contact
-
Via deze weg kunt u geen afspraak maken.